2.19 score from hupso.pl for:
aidsmap.com



HTML Content


Title hiv & aids information :: home

Length: 39, Words: 5
Description nam and aidsmap work to change lives by sharing information about hiv and aids. we believe independent, clear and accurate information is vital in the fight against hiv and aids

Length: 177, Words: 30
Keywords pusty
Robots
Charset UTF-8
Og Meta - Title exist
Og Meta - Description exist
Og Meta - Site name pusty
Tytuł powinien zawierać pomiędzy 10 a 70 znaków (ze spacjami), a mniej niż 12 słów w długości.
Meta opis powinien zawierać pomiędzy 50 a 160 znaków (łącznie ze spacjami), a mniej niż 24 słów w długości.
Kodowanie znaków powinny być określone , UTF-8 jest chyba najlepszy zestaw znaków, aby przejść z powodu UTF-8 jest bardziej międzynarodowy kodowaniem.
Otwarte obiekty wykresu powinny być obecne w stronie internetowej (więcej informacji na temat protokołu OpenGraph: http://ogp.me/)

SEO Content

Words/Characters 2697
Text/HTML 21.88 %
Headings H1 1
H2 1
H3 15
H4 7
H5 12
H6 3
H1
home
H2
conference news: croi 2017
H3
conference news: croi 2017
croi 2017: hepatitis c and hiv
croi 2017: prep
croi 2017: hiv treatment
nam endorses u=u consensus statement
sign up
recently diagnosed
clinic portal
find an hiv service
connect with nam
aidsmap hiv & aids news
editor's picks from other sources
a to z of topics
a to z of drugs
nam blog
H4 are people with hiv and hcv co-infection who are cured of hepatitis c with daas at increased risk for liver cancer?
bacterial vaginosis does not affect efficacy of oral prep in women
monoclonal antibodies show promise for hiv-positive people with limited treatment options
sti rates in prep users very high, but evidence that prep increases them is inconclusive
no evidence of risk compensation after circumcision in three african cohorts
accelerated linkage to hiv care improves retention in care by a third
better depression care could improve outcomes for hiv treatment programmes
H5 can florida's first needle exchange help curb hiv?
ukraine signs amicable agreement with gilead on hepatitis c drug
what we know about the new england prep trial
meet the man who stopped thousands of people becoming hiv-positive
didier lestrade: my first 30 years with hiv
egypt targets hepatitis c patients for medical tourism
hiv-positive kidney failure patients face greater hurdles in receiving necessary transplants
report highlights sexual health barriers for gay asian men in new south wales
women at the centre: who issues new guidance on the sexual and reproductive health and rights of women living with hiv
how to keep hiv cure-related trials ethical: the benefit/risk ratio challenge
personal story: an interview with gordon scott
messi visits egypt to promote hepatitis c treatment
H6 more
aidsmap news feeds
email updates
strong
nam publications
b
i
nam publications
em
Bolds strong 1
b 0
i 1
em 0
Zawartość strony internetowej powinno zawierać więcej niż 250 słów, z stopa tekst / kod jest wyższy niż 20%.
Pozycji używać znaczników (h1, h2, h3, ...), aby określić temat sekcji lub ustępów na stronie, ale zwykle, użyj mniej niż 6 dla każdego tagu pozycje zachować swoją stronę zwięzły.
Styl używać silnych i kursywy znaczniki podkreślić swoje słowa kluczowe swojej stronie, ale nie nadużywać (mniej niż 16 silnych tagi i 16 znaczników kursywy)

Statystyki strony

twitter:title pusty
twitter:description pusty
google+ itemprop=name pusty
Pliki zewnętrzne 20
Pliki CSS 10
Pliki javascript 10
Plik należy zmniejszyć całkowite odwołanie plików (CSS + JavaScript) do 7-8 maksymalnie.

Linki wewnętrzne i zewnętrzne

Linki 482
Linki wewnętrzne 461
Linki zewnętrzne 21
Linki bez atrybutu Title 482
Linki z atrybutem NOFOLLOW 0
Linki - Użyj atrybutu tytuł dla każdego łącza. Nofollow link jest link, który nie pozwala wyszukiwarkom boty zrealizują są odnośniki no follow. Należy zwracać uwagę na ich użytkowania

Linki wewnętrzne

home /
news /news
latest news /latest-news
are people with hiv and hcv co-infection who are cured of hepatitis c with daas at increased risk for liver cancer? /page/3120999/
bacterial vaginosis does not affect efficacy of oral prep in women /bacterial-vaginosis-does-not-affect-efficacy-of-oral-prep-in-women/page/3119911/
monoclonal antibodies show promise for hiv-positive people with limited treatment options /monoclonal-antibodies-show-promise-for-hiv-positive-people-with-limited-treatment-options/page/3119871/
features /latest-news#featureslist
unique case of prep failure without drug resistance reported from amsterdam /unique-case-of-prep-failure-without-drug-resistance-reported-from-amsterdam/page/3119879/
three-drug regimen beats xdr-tb in first trial /three-drug-regimen-beats-xdr-tb-in-first-trial/page/3119880/
new hepatitis c infections among hiv-positive gay men drop by half after direct-acting antiviral roll-out in netherlands /new-hepatitis-c-infections-among-hiv-positive-gay-men-drop-by-half-after-direct-acting-antiviral-roll-out-in-netherlands/page/3119881/
new hiv infections fall in the us, but demographic and geographic disparities persist /new-hiv-infections-fall-in-the-us-but-demographic-and-geographic-disparities-persist/page/3119877/
a benign circle: how a combination of factors has reduced hiv infections in one of the hardest-hit parts of africa /a-benign-circle-how-a-combination-of-factors-has-reduced-hiv-infections-in-one-of-the-hardest-hit-parts-of-africa/page/3119878/
news by topic /news/news-by-topic/page/1404239/
hiv update /hiv-update
news feeds /news/news-feeds/page/1444172/
conference news /conferences
hiv basics /hiv-basics
hiv & aids /hiv-basics/hiv-aids/page/1412437/
transmission /hiv-basics/transmission/page/1412438/
testing /hiv-basics/testing/page/1412439/
treatment /hiv-basics/treatment/page/1412440/
just diagnosed /hiv-basics/just-diagnosed/page/1412441/
looking for support in your area? /hiv-basics/looking-for-support-in-your-area/page/1412442/
topics /topics
testing and health monitoring /testing-and-health-monitoring/cat/1379/
hiv testing /hiv-testing/cat/1471/
health monitoring /health-monitoring/cat/1655/
hiv treatment /hiv-treatment/cat/1378/
treatment guidelines /treatment-guidelines/cat/1469/
starting treatment /starting-treatment/cat/1670/
side-effects /side-effects/cat/1463/
adherence /adherence/cat/1464/
drug interactions and pharmacokinetics /drug-interactions-and-pharmacokinetics/cat/1465/
treatment for women /treatment-for-women/cat/1467/
resistance /resistance/cat/1461/
changing treatment /changing-treatment/cat/1462/
treatment interruptions /treatment-interruptions/cat/1466/
treatment-experienced people /treatment-experienced-people/cat/1671/
new and experimental hiv treatments /new-and-experimental-hiv-treatments/cat/1673/
outcomes and prognosis /outcomes-and-prognosis/cat/1733/
the search for a cure /the-search-for-a-cure/cat/80321/
bad science and bogus treatments /bad-science-and-bogus-treatments/cat/80329/
transmission and prevention /transmission-and-prevention/cat/1377/
infectiousness and treatment as prevention /infectiousness-and-treatment-as-prevention/cat/1624/
prep /prep/cat/1623/
how transmission occurs /how-transmission-occurs/cat/1613/
sexual transmission /sexual-transmission/cat/1614/
medical procedures and other blood-borne exposure /medical-procedures-and-other-blood-borne-exposure/cat/1617/
low and theoretical transmission risks /low-and-theoretical-transmission-risks/cat/1618/
condoms and lubricant /condoms-and-lubricant/cat/1621/
harm reduction /harm-reduction/cat/81851/
circumcision /circumcision/cat/1622/
pep /pep/cat/1455/
behaviour change interventions /behaviour-change-interventions/cat/1620/
microbicides /microbicides/cat/1453/
vaccines /vaccines/cat/1459/
spermwashing /spermwashing/cat/1626/
epidemiology and behaviour /epidemiology-and-behaviour/cat/1734/
hiv prevention policy /hiv-prevention-policy/cat/80322/
structural factors /structural-factors/cat/80815/
social and legal issues /social-and-legal-issues/cat/1525/
telling people you have hiv /telling-people-you-have-hiv/cat/1537/
finding support /finding-support/cat/1535/
hiv and criminal law /hiv-and-criminal-law/cat/1686/
drug policy and policing /drug-policy-and-policing/cat/82203/
immigration /immigration/cat/1527/
money, benefits and housing /money-benefits-and-housing/cat/1529/
employment /employment/cat/1684/
religion and faith /religion-and-faith/cat/1644/
confidentiality, consent and medical ethics /confidentiality-consent-and-medical-ethics/cat/1687/
travel /travel/cat/1688/
end-of-life issues /end-of-life-issues/cat/1530/
experiences of stigma /experiences-of-stigma/cat/80323/
discrimination and the law /discrimination-and-the-law/cat/80324/
human rights /human-rights/cat/80325/
combatting stigma /combatting-stigma/cat/80326/
history of hiv and aids /history-of-hiv-and-aids/cat/80327/
people and personal stories /people-and-personal-stories/cat/82754/
hepatitis and hiv /hepatitis-and-hiv/cat/1508/
hepatitis c /hepatitis-c/cat/1509/
hepatitis b /hepatitis-b/cat/1510/
hepatitis a /hepatitis-a/cat/1627/
families and children /families-and-children/cat/1482/
prevention of mother-to-child transmission /prevention-of-mother-to-child-transmission/cat/1483/
hiv treatment in children /hiv-treatment-in-children/cat/1661/
infant feeding /infant-feeding/cat/1718/
conception /conception/cat/1488/
disclosure and children /disclosure-and-children/cat/1484/
diagnosing children /diagnosing-children/cat/1485/
hiv in children /hiv-in-children/cat/1660/
child developmental issues /child-developmental-issues/cat/1487/
support for families and children /support-for-families-and-children/cat/1662/
reproductive health /reproductive-health/cat/80812/
tuberculosis and hiv /tuberculosis-and-hiv/cat/1502/
tb vaccine /tb-vaccine/cat/1666/
tb transmission /tb-transmission/cat/1667/
tb prevention /tb-prevention/cat/1668/
tb symptoms /tb-symptoms/cat/1669/
tb diagnosis /tb-diagnosis/cat/1504/
tb treatment /tb-treatment/cat/1506/
drug-resistant tb /drug-resistant-tb/cat/1503/
tb services /tb-services/cat/1505/
hiv and sex /hiv-and-sex/cat/1540/
safer sex /safer-sex/cat/1546/
relationships and feelings /relationships-and-feelings/cat/1663/
contraception /contraception/cat/1544/
sexually transmitted infections /sexually-transmitted-infections/cat/1542/
health services and systems /health-services-and-systems/cat/1513/
delivery of care /delivery-of-care/cat/1519/
task shifting /task-shifting/cat/1717/
uk health services /uk-health-services/cat/1680/
palliative care /palliative-care/cat/1715/
epidemiology /epidemiology/cat/1682/
clinical trials /clinical-trials/cat/1683/
policy /policy/cat/1716/
activism /activism/cat/1645/
pharmaceutical industry /pharmaceutical-industry/cat/1646/
finance and funding /finance-and-funding/cat/1651/
global health initiatives /global-health-initiatives/cat/1650/
access to medicines and treatment /access-to-medicines-and-treatment/cat/80320/
retention and linkage to care /retention-and-linkage-to-care/cat/80814/
achieving the 90-90-90 target /achieving-the-90-90-90-target/cat/82765/
health problems /health-problems/cat/1489/
kidney problems /kidney-problems/cat/1723/
ageing and hiv /ageing-and-hiv/cat/1985/
mental and emotional health /mental-and-emotional-health/cat/1500/
opportunistic infections /opportunistic-infections/cat/1495/
cancer /cancer/cat/1679/
cardiovascular disease /cardiovascular-disease/cat/1493/
diabetes /diabetes/cat/1494/
malaria /malaria/cat/1499/
neurological and cognitive problems /neurological-and-cognitive-problems/cat/1719/
bone problems /bone-problems/cat/1724/
lipodystrophy /lipodystrophy/cat/1616/
malnutrition /malnutrition/cat/1642/
how hiv works /how-hiv-works/cat/1440/
what is hiv? /what-is-hiv/cat/1444/
what is aids? /what-is-aids/cat/1443/
how hiv causes disease /how-hiv-causes-disease/cat/1445/
healthy living /healthy-living/cat/1380/
mental and emotional health /mental-and-emotional-health/cat/1476/
nutrition /nutrition/cat/1480/
exercise /exercise/cat/1478/
recreational drug use /recreational-drug-use/cat/1477/
alcohol /alcohol/cat/1674/
smoking /smoking/cat/1481/
complementary therapies /complementary-therapies/cat/1675/
immunisations /immunisations/cat/1676/
sleep /sleep/cat/1677/
living well with a low cd4 count /living-well-with-a-low-cd4-count/cat/1678/
view full list of topics /topics
resources /resources
featured resources /resources
antiretroviral drugs chart /resources/antiretroviral-drugs-chart/page/1412453/
your next steps /your-next-steps/page/1412486/
view a full list of nam's resources /resources
the basics /thebasics
booklets /booklets
apps and online tools /apps
antiretroviral drugs chart /resources/antiretroviral-drugs-chart/page/1412453/
translations /translations
arabic /arabic
armenian /translations/armenian/page/3097762/
dutch (nederlands) /dutch
finnish (suomen kieli) /finnish
french (français) /fr
georgian /translations/georgian/page/3097990/
german (deutsch) /german
hebrew /hebrew
italian (italiano) /italian
kazakh (қазақ) /translations/kazakh/page/3098009/
norwegian (norsk) /norwegian
polish (polski) /polish
portuguese (português) /pt
romanian (română) /ro
russian (русский) /ru
somali /translations/somali/page/1563375/
spanish (español) /es
swedish (svenska) /swedish
thai /thai
turkish (türk) /turkish
ukrainian (yкраїнський) /translations/ukrainian-y/page/3097656/
translating our resources /translations/translating-our-resources/page/1443865/
e-atlas /e-atlas
search for hiv services across the world /e-atlas
get country-specific news and resources /e-atlas/country/
search for hiv services in the uk /e-atlas/uk/
about us /aboutus
nam blog /nam-blog
nam's director talks about prep and the decline in hiv diagnoses on bbc2's newsnight /nams-director-talks-about-prep-and-the-decline-in-hiv-diagnoses-on-bbc2s-newsnight/page/3119997/
nam endorses undetectable equals untransmittable (u=u) consensus statement /nam-endorses-undetectable-equals-untransmittable-uu-consensus-statement/page/3116508/
coming soon: news from croi 2017 /coming-soon-news-from-croi-2017/page/3113173/
who we are /aboutus/who-we-are/page/1276062/
what we do /aboutus/what-we-do/page/1277746/
maintaining high standards /aboutus/maintaining-high-standards/page/1439294/
how you can support us /aboutus/how-you-can-support-us/page/1439295/
how your support makes a difference /aboutus/how-your-support-makes-a-difference/page/1439296/
confidentiality /aboutus/confidentiality/page/1439297/
using nam’s resources /aboutus/using-nams-resources/page/1439298/
contact us /contact
donate /donate
more about us > /aboutus
- /when-science-community-and-political-will-come-together-we-can-end-the-epidemic-says-new-york-commissioner/page/3119005/
conference news: croi 2017 /when-science-community-and-political-will-come-together-we-can-end-the-epidemic-says-new-york-commissioner/page/3119005/
when science, community and political will come together, we can end the epidemic, says new york commissioner /when-science-community-and-political-will-come-together-we-can-end-the-epidemic-says-new-york-commissioner/page/3119005/
read our croi 2017 news bulletins /croi-2017/conference-bulletins/page/3112333/
visit our conference webpages for more news /croi-2017
- /when-science-community-and-political-will-come-together-we-can-end-the-epidemic-says-new-york-commissioner/page/3119005/
conference news: croi 2017 /when-science-community-and-political-will-come-together-we-can-end-the-epidemic-says-new-york-commissioner/page/3119005/
when science, community and political will come together, we can end the epidemic, says new york commissioner /when-science-community-and-political-will-come-together-we-can-end-the-epidemic-says-new-york-commissioner/page/3119005/
read our croi 2017 news bulletins /croi-2017/conference-bulletins/page/3112333/
visit our conference webpages for more news /croi-2017
- /new-hepatitis-c-infections-among-hiv-positive-gay-men-drop-by-half-after-direct-acting-antiviral-roll-out-in-netherlands/page/3118696/
croi 2017: hepatitis c and hiv /new-hepatitis-c-infections-among-hiv-positive-gay-men-drop-by-half-after-direct-acting-antiviral-roll-out-in-netherlands/page/3118696/
new hepatitis c infections among hiv-positive gay men drop by half after direct-acting antiviral roll-out in netherlands /new-hepatitis-c-infections-among-hiv-positive-gay-men-drop-by-half-after-direct-acting-antiviral-roll-out-in-netherlands/page/3118696/
visit our conference webpages for more news /croi-2017
- /sti-rates-in-prep-users-very-high-but-evidence-that-prep-increases-them-is-inconclusive/page/3119743/
croi 2017: prep /sti-rates-in-prep-users-very-high-but-evidence-that-prep-increases-them-is-inconclusive/page/3119743/
sti rates in prep users very high, but evidence that prep increases them is inconclusive /sti-rates-in-prep-users-very-high-but-evidence-that-prep-increases-them-is-inconclusive/page/3119743/
bacterial vaginosis does not affect efficacy of oral prep in women /bacterial-vaginosis-does-not-affect-efficacy-of-oral-prep-in-women/page/3119911/
unique case of prep failure without drug resistance reported from amsterdam /unique-case-of-prep-failure-without-drug-resistance-reported-from-amsterdam/page/3118230/
visit our conference webpages for more news /croi-2017
- /new-nnrti-doravirine-shows-good-efficacy-in-phase-3-study/page/3119117/
croi 2017: hiv treatment /new-nnrti-doravirine-shows-good-efficacy-in-phase-3-study/page/3119117/
integrase inhibitor bictegravir matches dolutegravir for first-line hiv treatment /integrase-inhibitor-bictegravir-matches-dolutegravir-for-first-line-hiv-treatment/page/3117463/
dual antiretroviral regimen maintains durable hiv suppression after switch /dual-antiretroviral-regimen-maintains-durable-hiv-suppression-after-switch/page/3117509/
new nnrti doravirine shows good efficacy in phase 3 study /new-nnrti-doravirine-shows-good-efficacy-in-phase-3-study/page/3119117/
visit our conference webpages for more news /croi-2017
- /nam-endorses-undetectable-equals-untransmittable-uu-consensus-statement/page/3116508/
nam endorses u=u consensus statement /nam-endorses-undetectable-equals-untransmittable-uu-consensus-statement/page/3116508/
find out more in our blog /nam-endorses-undetectable-equals-untransmittable-uu-consensus-statement/page/3116508/
sign up /bulletins
recently diagnosed /hiv-basics/just-diagnosed/page/1412441/
find an hiv service /e-atlas
connect with nam /aboutus/contact/social-media/page/1563489/
are people with hiv and hcv co-infection who are cured of hepatitis c with daas at increased risk for liver cancer? /page/3120999/
hepatitis and hiv /news/news-by-topic/hepatitis-and-hiv/cat/1508/page/1404239/
... /page/3120999/
bacterial vaginosis does not affect efficacy of oral prep in women /bacterial-vaginosis-does-not-affect-efficacy-of-oral-prep-in-women/page/3119911/
women /news/news-by-topic/women/cat/1735/page/1404239/
... /bacterial-vaginosis-does-not-affect-efficacy-of-oral-prep-in-women/page/3119911/
monoclonal antibodies show promise for hiv-positive people with limited treatment options /monoclonal-antibodies-show-promise-for-hiv-positive-people-with-limited-treatment-options/page/3119871/
new and experimental hiv treatments /news/news-by-topic/new-and-experimental-hiv-treatments/cat/1673/page/1404239/
... /monoclonal-antibodies-show-promise-for-hiv-positive-people-with-limited-treatment-options/page/3119871/
sti rates in prep users very high, but evidence that prep increases them is inconclusive /sti-rates-in-prep-users-very-high-but-evidence-that-prep-increases-them-is-inconclusive/page/3119743/
sexually transmitted infections /news/news-by-topic/sexually-transmitted-infections/cat/1542/page/1404239/
... /sti-rates-in-prep-users-very-high-but-evidence-that-prep-increases-them-is-inconclusive/page/3119743/
no evidence of risk compensation after circumcision in three african cohorts /no-evidence-of-risk-compensation-after-circumcision-in-three-african-cohorts/page/3119859/
circumcision /news/news-by-topic/circumcision/cat/1622/page/1404239/
... /no-evidence-of-risk-compensation-after-circumcision-in-three-african-cohorts/page/3119859/
accelerated linkage to hiv care improves retention in care by a third /accelerated-linkage-to-hiv-care-improves-retention-in-care-by-a-third/page/3119663/
retention and linkage to care /news/news-by-topic/retention-and-linkage-to-care/cat/80814/page/1404239/
... /accelerated-linkage-to-hiv-care-improves-retention-in-care-by-a-third/page/3119663/
better depression care could improve outcomes for hiv treatment programmes /better-depression-care-could-improve-outcomes-for-hiv-treatment-programmes/page/3119660/
mental and emotional health /news/news-by-topic/mental-and-emotional-health/cat/1500/page/1404239/
... /better-depression-care-could-improve-outcomes-for-hiv-treatment-programmes/page/3119660/
more news from aidsmap /latest-news
can florida's first needle exchange help curb hiv? /aggregator.ashx?url=https%3a%2f%2fwww.theatlantic.com%2fhealth%2farchive%2f2017%2f02%2fneedle-exchange-florida%2f517725%2f
ukraine signs amicable agreement with gilead on hepatitis c drug /aggregator.ashx?url=http%3a%2f%2fopen4business.com.ua%2fukraine-signs-amicable-agreement-u-s-gilead-biopharmaceutical-producer-hepatitis-c-drug%2f
what we know about the new england prep trial /aggregator.ashx?url=http%3a%2f%2fprepster.info%2f2017%2f02%2fknow-new-england-prep-trial%2f
meet the man who stopped thousands of people becoming hiv-positive /aggregator.ashx?url=https%3a%2f%2fwww.buzzfeed.com%2fpatrickstrudwick%2fmeet-the-man-who-stopped-thousands-of-people-becoming-hiv-po
didier lestrade: my first 30 years with hiv /aggregator.ashx?url=https%3a%2f%2fwww.vice.com%2fen_uk%2farticle%2fmy-first-30-years-with-hiv%3futm_source%3dvicetwitteruk
egypt targets hepatitis c patients for medical tourism /aggregator.ashx?url=https%3a%2f%2fwww.imtj.com%2fnews%2fegypt-targets-hepatitis-c-patients-medical-tourism%2f
hiv-positive kidney failure patients face greater hurdles in receiving necessary transplants /aggregator.ashx?url=http%3a%2f%2fwww.uab.edu%2fnews%2fservice%2fitem%2f8051
report highlights sexual health barriers for gay asian men in new south wales /aggregator.ashx?url=http%3a%2f%2fwww.starobserver.com.au%2fnews%2fnational-news%2fnew-south-wales-news%2fnew-paper-highlights-hiv-impact-asian-gay-men-nsw%2f155602
women at the centre: who issues new guidance on the sexual and reproductive health and rights of women living with hiv /aggregator.ashx?url=http%3a%2f%2fwww.who.int%2freproductivehealth%2ftopics%2fgender_rights%2fwomen-living-with-hiv%2fen%2f
how to keep hiv cure-related trials ethical: the benefit/risk ratio challenge /aggregator.ashx?url=http%3a%2f%2fblogs.bmj.com%2fmedical-ethics%2f2017%2f02%2f20%2fhow-to-keep-hiv-cure-related-trials-ethical-the-benefitrisk-ratio-challenge%2f
personal story: an interview with gordon scott /aggregator.ashx?url=http%3a%2f%2fwww.hivscotland.com%2fget-involved%2fpersonal-stories%2fan-interview-with-gordon-scott%2f
messi visits egypt to promote hepatitis c treatment /aggregator.ashx?url=http%3a%2f%2fwww.dailynewsegypt.com%2f2017%2f02%2f21%2fmessi-visits-egypt-promote-hepatitis-c-treatment%2f
more editor's picks /latest-news
access to medicines and treatment /access-to-medicines-and-treatment/cat/80320/
achieving the 90-90-90 target /achieving-the-90-90-90-target/cat/82765/
activism /activism/cat/1645/
adherence /adherence/cat/1464/
africans in the uk /africans-in-the-uk/cat/1732/
ageing and hiv /ageing-and-hiv/cat/1985/
alcohol /alcohol/cat/1674/
bad science and bogus treatments /bad-science-and-bogus-treatments/cat/80329/
behaviour change interventions /behaviour-change-interventions/cat/1620/
bone problems /bone-problems/cat/1724/
cancer /cancer/cat/1679/
cardiovascular disease /cardiovascular-disease/cat/1493/
cd4 count /cd4-count/cat/1656/
changing treatment /changing-treatment/cat/1462/
child developmental issues /child-developmental-issues/cat/1487/
circumcision /circumcision/cat/1622/
clinical trials /clinical-trials/cat/1683/
combatting stigma /combatting-stigma/cat/80326/
complementary therapies /complementary-therapies/cat/1675/
conception /conception/cat/1488/
condoms and lubricant /condoms-and-lubricant/cat/1621/
confidentiality, consent and medical ethics /confidentiality-consent-and-medical-ethics/cat/1687/
contraception /contraception/cat/1544/
delivery of care /delivery-of-care/cat/1519/
diabetes /diabetes/cat/1494/
diagnosing children /diagnosing-children/cat/1485/
disclosure and children /disclosure-and-children/cat/1484/
discrimination and the law /discrimination-and-the-law/cat/80324/
drug interactions and pharmacokinetics /drug-interactions-and-pharmacokinetics/cat/1465/
drug policy and policing /drug-policy-and-policing/cat/82203/
drug-resistant tb /drug-resistant-tb/cat/1503/
employment /employment/cat/1684/
end-of-life issues /end-of-life-issues/cat/1530/
epidemiology /epidemiology/cat/1682/
epidemiology and behaviour /epidemiology-and-behaviour/cat/1734/
exercise /exercise/cat/1478/
experiences of stigma /experiences-of-stigma/cat/80323/
families and children /families-and-children/cat/1482/
finance and funding /finance-and-funding/cat/1651/
finding support /finding-support/cat/1535/
global health initiatives /global-health-initiatives/cat/1650/
harm reduction /harm-reduction/cat/81851/
health monitoring /health-monitoring/cat/1655/
health monitoring in resource-limited settings /health-monitoring-in-resource-limited-settings/cat/1659/
health problems /health-problems/cat/1489/
health services and systems /health-services-and-systems/cat/1513/
healthy living /healthy-living/cat/1380/
hepatitis a /hepatitis-a/cat/1627/
hepatitis and hiv /hepatitis-and-hiv/cat/1508/
hepatitis b /hepatitis-b/cat/1510/
hepatitis c /hepatitis-c/cat/1509/
hepatitis c symptoms and diagnosis /hepatitis-c-symptoms-and-diagnosis/cat/1631/
hepatitis c transmission and prevention /hepatitis-c-transmission-and-prevention/cat/1628/
hepatitis c treatment /hepatitis-c-treatment/cat/1632/
hepatitis c treatment side-effects /hepatitis-c-treatment-side-effects/cat/80884/
history of hiv and aids /history-of-hiv-and-aids/cat/80327/
hiv and criminal law /hiv-and-criminal-law/cat/1686/
hiv and sex /hiv-and-sex/cat/1540/
hiv in children /hiv-in-children/cat/1660/
hiv prevention policy /hiv-prevention-policy/cat/80322/
hiv testing /hiv-testing/cat/1471/
hiv treatment /hiv-treatment/cat/1378/
hiv treatment in children /hiv-treatment-in-children/cat/1661/
how hiv causes disease /how-hiv-causes-disease/cat/1445/
how hiv works /how-hiv-works/cat/1440/
how transmission occurs /how-transmission-occurs/cat/1613/
human rights /human-rights/cat/80325/
immigration /immigration/cat/1527/
immunisations /immunisations/cat/1676/
infant feeding /infant-feeding/cat/1718/
infectiousness and treatment as prevention /infectiousness-and-treatment-as-prevention/cat/1624/
kidney problems /kidney-problems/cat/1723/
lipodystrophy /lipodystrophy/cat/1616/
living well with a low cd4 count /living-well-with-a-low-cd4-count/cat/1678/
low and theoretical transmission risks /low-and-theoretical-transmission-risks/cat/1618/
malaria /malaria/cat/1499/
malnutrition /malnutrition/cat/1642/
medical procedures and other blood-borne exposure /medical-procedures-and-other-blood-borne-exposure/cat/1617/
men who have sex with men (msm) /men-who-have-sex-with-men-msm/cat/1727/
mental and emotional health /mental-and-emotional-health/cat/1476/
mental and emotional health /mental-and-emotional-health/cat/1500/
microbicides /microbicides/cat/1453/
migrants /migrants/cat/1731/
money, benefits and housing /money-benefits-and-housing/cat/1529/
neurological and cognitive problems /neurological-and-cognitive-problems/cat/1719/
new and experimental hepatitis c treatment /new-and-experimental-hepatitis-c-treatment/cat/1635/
new and experimental hiv treatments /new-and-experimental-hiv-treatments/cat/1673/
nutrition /nutrition/cat/1480/
opportunistic infections /opportunistic-infections/cat/1495/
other tests /other-tests/cat/1658/
outcomes and prognosis /outcomes-and-prognosis/cat/1733/
palliative care /palliative-care/cat/1715/
people and personal stories /people-and-personal-stories/cat/82754/
people who inject drugs /people-who-inject-drugs/cat/1728/
pep /pep/cat/1455/
pharmaceutical industry /pharmaceutical-industry/cat/1646/
policy /policy/cat/1716/
populations /populations/cat/1726/
prep /prep/cat/1623/
prevention of mother-to-child transmission /prevention-of-mother-to-child-transmission/cat/1483/
prisoners /prisoners/cat/1730/
promoting hiv testing /promoting-hiv-testing/cat/1638/
recreational drug use /recreational-drug-use/cat/1477/
relationships and feelings /relationships-and-feelings/cat/1663/
religion and faith /religion-and-faith/cat/1644/
reproductive health /reproductive-health/cat/80812/
resistance /resistance/cat/1461/
retention and linkage to care /retention-and-linkage-to-care/cat/80814/
safer sex /safer-sex/cat/1546/
sex workers /sex-workers/cat/1729/
sexual transmission /sexual-transmission/cat/1614/
sexually transmitted infections /sexually-transmitted-infections/cat/1542/
side-effects /side-effects/cat/1463/
sleep /sleep/cat/1677/
smoking /smoking/cat/1481/
social and legal issues /social-and-legal-issues/cat/1525/
spermwashing /spermwashing/cat/1626/
starting treatment /starting-treatment/cat/1670/
structural factors /structural-factors/cat/80815/
support for families and children /support-for-families-and-children/cat/1662/
taking an hiv test /taking-an-hiv-test/cat/1637/
task shifting /task-shifting/cat/1717/
tb diagnosis /tb-diagnosis/cat/1504/
tb prevention /tb-prevention/cat/1668/
tb services /tb-services/cat/1505/
tb symptoms /tb-symptoms/cat/1669/
tb transmission /tb-transmission/cat/1667/
tb treatment /tb-treatment/cat/1506/
tb vaccine /tb-vaccine/cat/1666/
telling people you have hiv /telling-people-you-have-hiv/cat/1537/
testing and health monitoring /testing-and-health-monitoring/cat/1379/
testing policies and guidelines /testing-policies-and-guidelines/cat/1653/
the search for a cure /the-search-for-a-cure/cat/80321/
transgender people /transgender-people/cat/1528/
transmission and prevention /transmission-and-prevention/cat/1377/
travel /travel/cat/1688/
treatment for women /treatment-for-women/cat/1467/
treatment guidelines /treatment-guidelines/cat/1469/
treatment interruptions /treatment-interruptions/cat/1466/
treatment-experienced people /treatment-experienced-people/cat/1671/
tuberculosis and hiv /tuberculosis-and-hiv/cat/1502/
types of hiv tests /types-of-hiv-tests/cat/1649/
uk health services /uk-health-services/cat/1680/
vaccines /vaccines/cat/1459/
viral load /viral-load/cat/1657/
what is aids? /what-is-aids/cat/1443/
what is hiv? /what-is-hiv/cat/1444/
women /women/cat/1735/
young people /young-people/cat/1640/
abacavir (ziagen) /resources/treatmentsdirectory/drugs/abacavir-iziageni/page/1730880/
atazanavir (reyataz) /resources/treatmentsdirectory/drugs/atazanavir-ireyatazi/page/1730901/
atripla /resources/treatmentsdirectory/drugs/iatriplai/page/1730903/
darunavir (prezista) /resources/treatmentsdirectory/drugs/darunavir-iprezistai/page/1730953/
descovy /resources/treatmentsdirectory/drugs/idescovyi/page/3088857/
dolutegravir (tivicay) /resources/treatmentsdirectory/drugs/dolutegravir-itivicayi/page/2857993/
efavirenz (sustiva) /resources/treatmentsdirectory/drugs/efavirenz-isustivai/page/1730999/
elvitegravir (vitekta) /resources/treatmentsdirectory/drugs/elvitegravir-ivitektai/page/2858003/
emtricitabine (ftc, emtriva) /resources/treatmentsdirectory/drugs/emtricitabine-ftc-iemtrivai/page/1731063/
etravirine (intelence) /resources/treatmentsdirectory/drugs/etravirine-iintelencei/page/1731031/
eviplera /resources/treatmentsdirectory/drugs/ieviplerai/page/2188046/
evotaz /resources/treatmentsdirectory/drugs/ievotazi/page/3088910/
fosamprenavir (telzir, lexiva) /resources/treatmentsdirectory/drugs/fosamprenavir-itelziri-ilexivai/page/1731036/
genvoya /resources/treatmentsdirectory/drugs/igenvoyai/page/3088881/
kivexa (abacavir/3tc) /resources/treatmentsdirectory/drugs/ikivexai-abacavir3tc/page/1731081/
lamivudine (3tc, epivir) /resources/treatmentsdirectory/drugs/lamivudine-3tc-iepiviri/page/1730859/
lopinavir/ritonavir (kaletra) /resources/treatmentsdirectory/drugs/lopinavirritonavir-ikaletrai/page/1731082/
maraviroc (celsentri) /resources/treatmentsdirectory/drugs/maraviroc-icelsentrii/page/1731120/
nevirapine (viramune) /resources/treatmentsdirectory/drugs/nevirapine-iviramunei/page/1731152/
odefsey /resources/treatmentsdirectory/drugs/iodefseyi/page/3088883/
raltegravir (isentress) /resources/treatmentsdirectory/drugs/raltegravir-iisentressi/page/1731168/
rezolsta /resources/treatmentsdirectory/drugs/irezolstai/page/3088912/
rilpivirine (edurant) /resources/treatmentsdirectory/drugs/rilpivirine-ieduranti/page/1731269/
ritonavir (norvir) /resources/treatmentsdirectory/drugs/ritonavir-inorviri/page/1731169/
stribild /resources/treatmentsdirectory/drugs/istribildi/page/2857997/
tenofovir (viread) /resources/treatmentsdirectory/drugs/tenofovir-ivireadi/page/1731221/
triumeq /resources/treatmentsdirectory/drugs/itriumeqi/page/3088919/
truvada (tenofovir/ftc) /resources/treatmentsdirectory/drugs/itruvadai-tenofovirftc/page/1731265/
zidovudine (azt, retrovir) /resources/treatmentsdirectory/drugs/zidovudine-azt-iretroviri/page/1730919/
nam's director talks about prep and the decline in hiv diagnoses on bbc2's newsnight /nams-director-talks-about-prep-and-the-decline-in-hiv-diagnoses-on-bbc2s-newsnight/page/3119997/
nam endorses undetectable equals untransmittable (u=u) consensus statement /nam-endorses-undetectable-equals-untransmittable-uu-consensus-statement/page/3116508/
coming soon: news from croi 2017 /coming-soon-news-from-croi-2017/page/3113173/
new editions of 22 leaflets in the basics series /new-editions-of-22-leaflets-in-ithe-basicsi-series/page/3111817/
more /nam-blog
nam’s information /accessibility-terms-of-use/page/1404310/
subscribe to our news feeds /news/news-feeds/page/1444172/
get the latest hiv news delivered to your inbox /bulletins
sitemap /sitemap/page/1404305/
accessibility & terms of use /accessibility-terms-of-use/page/1404310/
privacy & cookies /privacy-amp-cookies/page/1404311/
feedback /feedback/page/1404313/
contact us /contact-us/page/1446756/

Linki zewnętrzne

nam http://www.aidsmap.com
aidsmap http://www.aidsmap.com
view a webcast of this presentation on the conference website http://www.croiwebcasts.org/console/player/33560?mediatype=slidevideo&
view a webcast of this presentation on the conference website http://www.croiwebcasts.org/console/player/33560?mediatype=slidevideo&
read the full statement https://www.preventionaccess.org/consensus
clinic portal http://clinic.nam.org.uk/page/2945735
the information standard certified member http://www.england.nhs.uk/tis/
sign the community consensus statement on access to hiv treatment and its use for prevention http://www.hivt4p.org/
community consensus statement on access to hiv treatment and its use for prevention http://www.hivt4p.org/
community consensus statement http://www.hivt4p.org
read it http://www.hivt4p.org/#content
sign it http://www.hivt4p.org/#profile-form
share it http://www.hivt4p.org/#share-links
http://www.avac.org/
http://www.eatg.org
http://msmgf.org/
http://www.gnpplus.net/
http://i-base.info/
http://www.aidsalliance.org/
http://itpcglobal.org/
http://www.aidsmap.com/

Zdjęcia

Zdjęcia 14
Zdjęcia bez atrybutu ALT 9
Zdjęcia bez atrybutu TITLE 14
Korzystanie Obraz ALT i TITLE atrybutu dla każdego obrazu.

Zdjęcia bez atrybutu TITLE

/site/file/1213444/file.png
/v636108409673330000/file/1213110/resize/w106~c0,0,106,75/drug_chart_sep_2016_web_ready.png
/v635735895820000000/file/1187277/resize/w106~c0,0,106,75/your_next_steps_web.png
http://images.aidsmap.com/v636233786238830000/file/1213706/resize/w106~c0,0,106,75/newsnight_matthew_1000_707.jpg
http://images.aidsmap.com/v636227742430470000/file/1213647/resize/w106~c0,0,106,75/undetectable_untransmittable_5_005_.png
http://images.aidsmap.com/v636197379761300000/file/1213598/resize/w106~c0,0,106,75/croi_2017_1000_707_eng.png
http://images.aidsmap.com/v636233505234530000/file/1213689/resize/w297~c0,0,297,210/demetred.jpg
http://images.aidsmap.com/v636233505234530000/file/1213689/resize/w114~c0,0,114,80/demetred.jpg
http://images.aidsmap.com/v636229272670000000/file/1213667/resize/w114~c0,0,114,80/virlogeux_rijnders_hcv_1000_707.jpg
http://images.aidsmap.com/v636233691090000000/file/1213701/resize/w114~c0,0,114,80/matthewgolden_1000_707.jpg
http://images.aidsmap.com/v636233505020500000/file/1213686/resize/w114~c0,0,114,80/kathleensquires.jpg
http://images.aidsmap.com/v636227742430470000/file/1213647/resize/w114~c0,0,114,80/undetectable_untransmittable_5_005_.png
/site/file/1213445/file.png
/site/file/1213446/file.png

Zdjęcia bez atrybutu ALT

/site/file/1213444/file.png
http://images.aidsmap.com/v636233505234530000/file/1213689/resize/w297~c0,0,297,210/demetred.jpg
http://images.aidsmap.com/v636233505234530000/file/1213689/resize/w114~c0,0,114,80/demetred.jpg
http://images.aidsmap.com/v636229272670000000/file/1213667/resize/w114~c0,0,114,80/virlogeux_rijnders_hcv_1000_707.jpg
http://images.aidsmap.com/v636233691090000000/file/1213701/resize/w114~c0,0,114,80/matthewgolden_1000_707.jpg
http://images.aidsmap.com/v636233505020500000/file/1213686/resize/w114~c0,0,114,80/kathleensquires.jpg
http://images.aidsmap.com/v636227742430470000/file/1213647/resize/w114~c0,0,114,80/undetectable_untransmittable_5_005_.png
/site/file/1213445/file.png
/site/file/1213446/file.png

Ranking:


Alexa Traffic
Daily Global Rank Trend
Daily Reach (Percent)









Majestic SEO











Text on page:

low graphics text only --> nam aidsmap hiv & aids - sharing knowledge, changing lives home news latest newsare people with hiv and hcv co-infection who are cured of hepatitis c with daas at increased risk for liver cancer? 11 hours agobacterial vaginosis does not affect efficacy of oral prep in women 23 february 2017monoclonal antibodies show promise for hiv-positive people with limited treatment options 22 february 2017featuresunique case of prep failure without drug resistance reported from amsterdamthree-drug regimen beats xdr-tb in first trialnew hepatitis c infections among hiv-positive gay men drop by half after direct-acting antiviral roll-out in netherlandsnew hiv infections fall in the us, but demographic and geographic disparities persista benign circle: how a combination of factors has reduced hiv infections in one of the hardest-hit parts of africa news by topic all our news, features and news selected from other sources. hiv update a fortnightly summary of hiv research news. news feeds conference news news from the conference on retroviruses and opportunistic infections (croi 2017). hiv basics hiv & aids what is hiv? and what is aids? find answers to some common questions in this section. transmission how is hiv transmitted - and how is it not transmitted? find out the answers in this section. testing worried you might have hiv? have an hiv test - it's the only way to know for sure. treatment hiv treatment is not a cure, but it is keeping millions of people well. start learning about it in this section. just diagnosed in this section we have answered some of the questions you might have if you have just found out you have hiv. looking for support in your area? find healthcare services and support. topics testing and health monitoring hiv testing | health monitoring hiv treatment treatment guidelines | starting treatment | side-effects | adherence | drug interactions and pharmacokinetics | treatment for women | resistance | changing treatment | treatment interruptions | treatment-experienced people | new and experimental hiv treatments | outcomes and prognosis | the search for a cure | bad science and bogus treatments transmission and prevention infectiousness and treatment as prevention | prep | how transmission occurs | sexual transmission | medical procedures and other blood-borne exposure | low and theoretical transmission risks | condoms and lubricant | harm reduction | circumcision | pep | behaviour change interventions | microbicides | vaccines | spermwashing | epidemiology and behaviour | hiv prevention policy | structural factors social and legal issues telling people you have hiv | finding support | hiv and criminal law | drug policy and policing | immigration | money, benefits and housing | employment | religion and faith | confidentiality, consent and medical ethics | travel | end-of-life issues | experiences of stigma | discrimination and the law | human rights | combatting stigma | history of hiv and aids | people and personal stories hepatitis and hiv hepatitis c | hepatitis b | hepatitis a families and children prevention of mother-to-child transmission | hiv treatment in children | infant feeding | conception | disclosure and children | diagnosing children | hiv in children | child developmental issues | support for families and children | reproductive health tuberculosis and hiv tb vaccine | tb transmission | tb prevention | tb symptoms | tb diagnosis | tb treatment | drug-resistant tb | tb services hiv and sex safer sex | relationships and feelings | contraception | sexually transmitted infections health services and systems delivery of care | task shifting | uk health services | palliative care | epidemiology | clinical trials | policy | activism | pharmaceutical industry | finance and funding | global health initiatives | access to medicines and treatment | retention and linkage to care | achieving the 90-90-90 target health problems kidney problems | ageing and hiv | mental and emotional health | opportunistic infections | cancer | cardiovascular disease | diabetes | malaria | neurological and cognitive problems | bone problems | lipodystrophy | malnutrition how hiv works what is hiv? | what is aids? | how hiv causes disease healthy living mental and emotional health | nutrition | exercise | recreational drug use | alcohol | smoking | complementary therapies | immunisations | sleep | living well with a low cd4 count view full list of topics resources featured resourcesantiretroviral drugs charta one-page reference guide to the anti-hiv drugs licensed for use in the european union, with information on formulation, dosing, key side-effects and food restrictions.your next stepsa booklet with information for people who’ve just found out they have hiv. view a full list of nam's resources the basics an introduction to key issues about hiv treatment and living with hiv, presented as a series of illustrated leaflets. booklets our award-winning series of booklets, with each title providing a comprehensive overview of one aspect of living with hiv. apps and online tools a range of interactive tools to support people living with hiv to get involved in decisions about their treatment and care. antiretroviral drugs chart a one-page reference guide to the anti-hiv drugs licensed for use in the european union, with information on formulation, dosing, key side-effects and food restrictions. translations arabic armenian dutch (nederlands) finnish (suomen kieli) french (français) georgian german (deutsch) hebrew italian (italiano) kazakh (қазақ) norwegian (norsk) polish (polski) portuguese (português) romanian (română) russian (русский) somali spanish (español) swedish (svenska) thai turkish (türk) ukrainian (yкраїнський) translating our resources e-atlas search for hiv services across the worldfind contact details for over 900 key organisations in more than 189 countriesget country-specific news and resourcesan instant guide to hiv & aids in countries and regions around the worldsearch for hiv services in the ukthe most comprehensive listing of hiv-related services in the uk about us nam blognam's director talks about prep and the decline in hiv diagnoses on bbc2's newsnight 22 february 2017nam’s executive director, matthew hodson, appeared on bbc2’s newsnight on tuesday...nam endorses undetectable equals untransmittable (u=u) consensus statement 09 february 2017nam aidsmap, one of the foremost sources of hiv information in...coming soon: news from croi 2017 30 january 2017the annual conference on retroviruses and opportunistic infections (croi) is... who we are what we do maintaining high standards how you can support us how your support makes a difference confidentiality using nam’s resources contact us donate home nam works to change lives by sharing information about hiv and aids. we believe independent, clear and accurate information is vital in the fight against hiv and aids. more about us > conference news: croi 2017 the conference on retroviruses and opportunistic infections (croi 2017) took place in seattle, usa earlier this month.when science, community and political will come together, we can end the epidemic, says new york commissionerview a webcast of this presentation on the conference websiteread our croi 2017 news bulletinsvisit our conference webpages for more news conference news: croi 2017 the conference on retroviruses and opportunistic infections (croi 2017) took place in seattle, usa earlier this month.when science, community and political will come together, we can end the epidemic, says new york commissionerview a webcast of this presentation on the conference websiteread our croi 2017 news bulletinsvisit our conference webpages for more news croi 2017: hepatitis c and hiv researchers in the netherlands have seen a dramatic decline in acute hepatitis c virus infections among hiv-positive gay men after a roll-out of direct-acting antivirals.new hepatitis c infections among hiv-positive gay men drop by half after direct-acting antiviral roll-out in netherlandsvisit our conference webpages for more news croi 2017: prep prep (pre-exposure prophylaxis) news from croi 2017. sti rates in prep users very high, but evidence that prep increases them is inconclusivebacterial vaginosis does not affect efficacy of oral prep in womenunique case of prep failure without drug resistance reported from amsterdamvisit our conference webpages for more news croi 2017: hiv treatment the conference on retroviruses and opportunistic infections (croi 2017) took place in seattle, usa earlier this month. integrase inhibitor bictegravir matches dolutegravir for first-line hiv treatmentdual antiretroviral regimen maintains durable hiv suppression after switchnew nnrti doravirine shows good efficacy in phase 3 studyvisit our conference webpages for more news nam endorses u=u consensus statement nam strongly endorses the 'undetectable equals untransmittable’ (u=u) consensus statement on the risk of sexual transmission of hiv from a person living with hiv who has an undetectable viral load. the statement is issued by the prevention access campaign.find out more in our blogread the full statement sign up recently diagnosed clinic portal find an hiv service connect with nam aidsmap hiv & aids news are people with hiv and hcv co-infection who are cured of hepatitis c with daas at increased risk for liver cancer? new hepatitis and hiv liz highleyman | 11 hours ago people with hiv and hepatitis c virus (hcv) co-infection who are successfully treated for hepatitis c using interferon-free direct-acting antiviral (daa) therapy do not appear to have an increased likelihood of developing hepatocellular ... bacterial vaginosis does not affect efficacy of oral prep in women women gus cairns | 23 february 2017 research presented at the conference on retroviruses and opportunistic infections (croi 2017) found that the efficacy of oral pre-exposure prophylaxis (prep) for women was not affected by bacterial vaginosis (bv) – ... monoclonal antibodies show promise for hiv-positive people with limited treatment options new and experimental hiv treatments liz highleyman | 22 february 2017 a pair of long-acting monoclonal antibodies that prevent hiv from entering human cells – ibalizumab and pro 140 – may offer new treatment options for people with highly resistant virus and limited ... sti rates in prep users very high, but evidence that prep increases them is inconclusive sexually transmitted infections gus cairns | 22 february 2017 a study of pre-exposure prophylaxis (prep) users presented at the conference on retroviruses and opportunistic infections (croi 2017) last week in seattle, showed that prep users had very high rates ... no evidence of risk compensation after circumcision in three african cohorts circumcision roger pebody | 22 february 2017 three large studies in south africa, zimbabwe and kenya have found no evidence that men who have been circumcised have more sexual risk behaviours than uncircumcised men. two of the studies were ... accelerated linkage to hiv care improves retention in care by a third retention and linkage to care carole leach-lemens | 21 february 2017 close to 60% of adults benefiting from point-of-care cd4 cell count testing at hiv testing sites, accelerated antiretroviral therapy (art) initiation and sms appointment reminders were retained in care after one year, ... better depression care could improve outcomes for hiv treatment programmes mental and emotional health roger pebody | 21 february 2017 improved management of depression and other mental health disorders has the potential to improve the outcomes of hiv treatment programmes, pamela collins of the national institute of mental health told the conference on ... more news from aidsmap editor's picks from other sources harm reduction can florida's first needle exchange help curb hiv? the atlantic | 7 hours ago hepatitis c treatment ukraine signs amicable agreement with gilead on hepatitis c drug interfax ukraine | 8 hours ago prep what we know about the new england prep trial prepster | 10 hours ago people and personal stories meet the man who stopped thousands of people becoming hiv-positive buzzfeed news | 26 february 2017 people and personal stories didier lestrade: my first 30 years with hiv vice | 26 february 2017 hepatitis c treatment egypt targets hepatitis c patients for medical tourism international medical tourism journal | 24 february 2017 kidney problems hiv-positive kidney failure patients face greater hurdles in receiving necessary transplants university of alabama birmingham press release | 24 february 2017 epidemiology and behaviour report highlights sexual health barriers for gay asian men in new south wales star observer | 23 february 2017 women women at the centre: who issues new guidance on the sexual and reproductive health and rights of women living with hiv world health organization | 23 february 2017 confidentiality, consent and medical ethics how to keep hiv cure-related trials ethical: the benefit/risk ratio challenge bmj blogs | 22 february 2017 history of hiv and aids personal story: an interview with gordon scott hiv scotland | 22 february 2017 hepatitis c treatment messi visits egypt to promote hepatitis c treatment daily news egypt | 22 february 2017 more editor's picks a to z of topics access to medicines and treatment achieving the 90-90-90 target activism adherence africans in the uk ageing and hiv alcohol bad science and bogus treatments behaviour change interventions bone problems cancer cardiovascular disease cd4 count changing treatment child developmental issues circumcision clinical trials combatting stigma complementary therapies conception condoms and lubricant confidentiality, consent and medical ethics contraception delivery of care diabetes diagnosing children disclosure and children discrimination and the law drug interactions and pharmacokinetics drug policy and policing drug-resistant tb employment end-of-life issues epidemiology epidemiology and behaviour exercise experiences of stigma families and children finance and funding finding support global health initiatives harm reduction health monitoring health monitoring in resource-limited settings health problems health services and systems healthy living hepatitis a hepatitis and hiv hepatitis b hepatitis c hepatitis c symptoms and diagnosis hepatitis c transmission and prevention hepatitis c treatment hepatitis c treatment side-effects history of hiv and aids hiv and criminal law hiv and sex hiv in children hiv prevention policy hiv testing hiv treatment hiv treatment in children how hiv causes disease how hiv works how transmission occurs human rights immigration immunisations infant feeding infectiousness and treatment as prevention kidney problems lipodystrophy living well with a low cd4 count low and theoretical transmission risks malaria malnutrition medical procedures and other blood-borne exposure men who have sex with men (msm) mental and emotional health mental and emotional health microbicides migrants money, benefits and housing neurological and cognitive problems new and experimental hepatitis c treatment new and experimental hiv treatments nutrition opportunistic infections other tests outcomes and prognosis palliative care people and personal stories people who inject drugs pep pharmaceutical industry policy populations prep prevention of mother-to-child transmission prisoners promoting hiv testing recreational drug use relationships and feelings religion and faith reproductive health resistance retention and linkage to care safer sex sex workers sexual transmission sexually transmitted infections side-effects sleep smoking social and legal issues spermwashing starting treatment structural factors support for families and children taking an hiv test task shifting tb diagnosis tb prevention tb services tb symptoms tb transmission tb treatment tb vaccine telling people you have hiv testing and health monitoring testing policies and guidelines the search for a cure transgender people transmission and prevention travel treatment for women treatment guidelines treatment interruptions treatment-experienced people tuberculosis and hiv types of hiv tests uk health services vaccines viral load what is aids? what is hiv? women young people a to z of drugs abacavir (ziagen) atazanavir (reyataz) atripla darunavir (prezista) descovy dolutegravir (tivicay) efavirenz (sustiva) elvitegravir (vitekta) emtricitabine (ftc, emtriva) etravirine (intelence) eviplera evotaz fosamprenavir (telzir, lexiva) genvoya kivexa (abacavir/3tc) lamivudine (3tc, epivir) lopinavir/ritonavir (kaletra) maraviroc (celsentri) nevirapine (viramune) odefsey raltegravir (isentress) rezolsta rilpivirine (edurant) ritonavir (norvir) stribild tenofovir (viread) triumeq truvada (tenofovir/ftc) zidovudine (azt, retrovir) nam blog nam's director talks about prep and the decline in hiv diagnoses on bbc2's newsnight 22 february 2017 nam endorses undetectable equals untransmittable (u=u) consensus statement 09 february 2017 coming soon: news from croi 2017 30 january 2017 new editions of 22 leaflets in the basics series 19 january 2017 more the information standard certified member nam’s information is intended to support, rather than replace, consultation with a healthcare professional. talk to your doctor or another member of your healthcare team for advice tailored to your situation. aidsmap news feeds subscribe to our news feeds email updates get the latest hiv news delivered to your inbox share/bookmark this page   facebook   twitter   stumbleupon   linkedin   reddit   digg   delicious   technorati   g bookmarks   y! bookmarks --> nam publications registered office: acorn house, 314-320 gray’s inn road, london, wc1x 8dp company limited by guarantee. registered in england & wales, number: 2707596 registered charity, number: 1011220 © nam publications, 2017. all rights reserved. nam is not responsible for the content of external websites. sitemapaccessibility & terms of useprivacy & cookiesfeedbackcontact usmobile version--> sign the community consensus statement on access to hiv treatment and its use for prevention more community consensus statement on access to hiv treatment and its use for prevention together, we can make it happen we can end hiv soon if people have equal access to hiv drugs as treatment and as prep, and have free choice over whether to take them. launched today, the community consensus statement is a basic set of principles aimed at making sure that happens. read it sign it share it the community consensus statement is a joint initiative of avac, eatg, msmgf, gnp+, hiv i-base, the international hiv/aids alliance, itpc and nam/aidsmap close this content was checked for accuracy at the time it was written. it may have been superseded by more recent developments. nam recommends checking whether this is the most current information when making decisions that may affect your health. nam’s information is intended to support, rather than replace, consultation with a healthcare professional. talk to your doctor or another member of your healthcare team for advice tailored to your situation.


Here you find all texts from your page as Google (googlebot) and others search engines seen it.

Words density analysis:

Numbers of all words: 2887

One word

Two words phrases

Three words phrases

and - 4.68% (135)
men - 3.6% (104)
hiv - 3.53% (102)
the - 3.36% (97)
for - 1.73% (50)
new - 1.66% (48)
treatment - 1.66% (48)
our - 1.63% (47)
2017 - 1.42% (41)
pro - 1.14% (33)
health - 1.14% (33)
news - 1.11% (32)
sti - 1% (29)
are - 0.97% (28)
hepatitis - 0.97% (28)
with - 0.97% (28)
out - 0.83% (24)
prep - 0.76% (22)
people - 0.76% (22)
nam - 0.76% (22)
february - 0.73% (21)
use - 0.73% (21)
aids - 0.66% (19)
drug - 0.66% (19)
you - 0.66% (19)
have - 0.62% (18)
conference - 0.62% (18)
care - 0.62% (18)
infections - 0.59% (17)
croi - 0.59% (17)
how - 0.55% (16)
child - 0.55% (16)
sex - 0.52% (15)
prevent - 0.52% (15)
transmission - 0.52% (15)
test - 0.52% (15)
more - 0.48% (14)
vice - 0.48% (14)
prevention - 0.48% (14)
can - 0.48% (14)
end - 0.48% (14)
mental - 0.45% (13)
one - 0.45% (13)
this - 0.42% (12)
children - 0.42% (12)
from - 0.42% (12)
who - 0.38% (11)
women - 0.38% (11)
your - 0.38% (11)
support - 0.38% (11)
service - 0.38% (11)
information - 0.35% (10)
all - 0.35% (10)
virus - 0.35% (10)
other - 0.35% (10)
statement - 0.35% (10)
not - 0.35% (10)
... - 0.35% (10)
services - 0.35% (10)
viral - 0.35% (10)
opportunistic - 0.31% (9)
sources - 0.31% (9)
about - 0.31% (9)
sure - 0.31% (9)
testing - 0.31% (9)
man - 0.31% (9)
get - 0.31% (9)
problems - 0.31% (9)
sexual - 0.31% (9)
living - 0.31% (9)
issues - 0.28% (8)
consensus - 0.28% (8)
risk - 0.28% (8)
high - 0.28% (8)
find - 0.28% (8)
what - 0.28% (8)
that - 0.28% (8)
page - 0.28% (8)
harm - 0.24% (7)
retroviruses - 0.24% (7)
(croi - 0.24% (7)
medical - 0.24% (7)
count - 0.24% (7)
access - 0.24% (7)
drugs - 0.24% (7)
search - 0.24% (7)
hiv-positive - 0.24% (7)
after - 0.21% (6)
community - 0.21% (6)
view - 0.21% (6)
resources - 0.21% (6)
policy - 0.21% (6)
aidsmap - 0.21% (6)
come - 0.21% (6)
cure - 0.21% (6)
guide - 0.21% (6)
person - 0.21% (6)
behaviour - 0.21% (6)
2017) - 0.21% (6)
emotional - 0.17% (5)
epidemiology - 0.17% (5)
side-effects - 0.17% (5)
personal - 0.17% (5)
healthcare - 0.17% (5)
monitoring - 0.17% (5)
exposure - 0.17% (5)
treatments - 0.17% (5)
low - 0.17% (5)
limited - 0.17% (5)
its - 0.17% (5)
was - 0.17% (5)
trial - 0.17% (5)
ago - 0.17% (5)
hours - 0.17% (5)
liver - 0.17% (5)
very - 0.17% (5)
efficacy - 0.17% (5)
webpages - 0.17% (5)
place - 0.17% (5)
hiv? - 0.17% (5)
read - 0.17% (5)
transmitted - 0.17% (5)
affect - 0.17% (5)
blog - 0.14% (4)
rights - 0.14% (4)
vaccine - 0.14% (4)
star - 0.14% (4)
families - 0.14% (4)
equal - 0.14% (4)
stigma - 0.14% (4)
talk - 0.14% (4)
retention - 0.14% (4)
basic - 0.14% (4)
linkage - 0.14% (4)
improve - 0.14% (4)
stories - 0.14% (4)
press - 0.14% (4)
antiretroviral - 0.14% (4)
kidney - 0.14% (4)
full - 0.14% (4)
endorses - 0.14% (4)
undetectable - 0.14% (4)
key - 0.14% (4)
confidentiality - 0.14% (4)
using - 0.14% (4)
nam’s - 0.14% (4)
seattle, - 0.14% (4)
usa - 0.14% (4)
users - 0.14% (4)
gus - 0.14% (4)
cd4 - 0.14% (4)
evidence - 0.14% (4)
u=u - 0.14% (4)
nutrition - 0.14% (4)
sign - 0.14% (4)
bacterial - 0.14% (4)
disease - 0.14% (4)
than - 0.14% (4)
law - 0.14% (4)
cancer - 0.14% (4)
resistance - 0.14% (4)
outcomes - 0.14% (4)
topic - 0.14% (4)
africa - 0.14% (4)
first - 0.14% (4)
circumcision - 0.14% (4)
experimental - 0.14% (4)
gay - 0.14% (4)
science - 0.14% (4)
oral - 0.14% (4)
has - 0.14% (4)
section - 0.14% (4)
antiviral - 0.14% (4)
change - 0.14% (4)
show - 0.14% (4)
direct-acting - 0.14% (4)
but - 0.14% (4)
found - 0.14% (4)
vaginosis - 0.14% (4)
contact - 0.1% (3)
national - 0.1% (3)
does - 0.1% (3)
when - 0.1% (3)
over - 0.1% (3)
egypt - 0.1% (3)
target - 0.1% (3)
most - 0.1% (3)
director - 0.1% (3)
month. - 0.1% (3)
decline - 0.1% (3)
report - 0.1% (3)
them - 0.1% (3)
world - 0.1% (3)
increased - 0.1% (3)
hiv. - 0.1% (3)
cell - 0.1% (3)
resistant - 0.1% (3)
topics - 0.1% (3)
pre-exposure - 0.1% (3)
prophylaxis - 0.1% (3)
booklet - 0.1% (3)
- 0.1% (3)
monoclonal - 0.1% (3)
antibodies - 0.1% (3)
list - 0.1% (3)
may - 0.1% (3)
well - 0.1% (3)
clinic - 0.1% (3)
nam's - 0.1% (3)
presented - 0.1% (3)
three - 0.1% (3)
series - 0.1% (3)
failure - 0.1% (3)
liz - 0.1% (3)
ratio - 0.1% (3)
were - 0.1% (3)
works - 0.1% (3)
newsnight - 0.1% (3)
start - 0.1% (3)
just - 0.1% (3)
earlier - 0.1% (3)
basics - 0.1% (3)
options - 0.1% (3)
research - 0.1% (3)
took - 0.1% (3)
history - 0.1% (3)
registered - 0.1% (3)
inn - 0.1% (3)
human - 0.1% (3)
netherlands - 0.1% (3)
2017: - 0.1% (3)
rates - 0.1% (3)
ethics - 0.1% (3)
consent - 0.1% (3)
confidentiality, - 0.1% (3)
soon - 0.1% (3)
roll-out - 0.1% (3)
changing - 0.1% (3)
factors - 0.1% (3)
together, - 0.1% (3)
--> - 0.1% (3)
initiative - 0.1% (3)
aids? - 0.1% (3)
feeds - 0.1% (3)
hcv - 0.1% (3)
section. - 0.1% (3)
trials - 0.1% (3)
equals - 0.1% (3)
untransmittable - 0.1% (3)
(u=u) - 0.1% (3)
co-infection - 0.1% (3)
coming - 0.1% (3)
know - 0.1% (3)
among - 0.1% (3)
sexually - 0.1% (3)
reproductive - 0.1% (3)
member - 0.1% (3)
guidelines - 0.1% (3)
symptoms - 0.1% (3)
january - 0.1% (3)
diagnosis - 0.1% (3)
reduction - 0.1% (3)
presentation - 0.07% (2)
appear - 0.07% (2)
reported - 0.07% (2)
increases - 0.07% (2)
websiteread - 0.07% (2)
drop - 0.07% (2)
high, - 0.07% (2)
without - 0.07% (2)
2017. - 0.07% (2)
highleyman - 0.07% (2)
dolutegravir - 0.07% (2)
half - 0.07% (2)
regimen - 0.07% (2)
therapy - 0.07% (2)
bulletinsvisit - 0.07% (2)
south - 0.07% (2)
case - 0.07% (2)
latest - 0.07% (2)
standard - 0.07% (2)
intended - 0.07% (2)
support, - 0.07% (2)
rather - 0.07% (2)
replace, - 0.07% (2)
consultation - 0.07% (2)
professional. - 0.07% (2)
doctor - 0.07% (2)
another - 0.07% (2)
team - 0.07% (2)
advice - 0.07% (2)
tailored - 0.07% (2)
situation. - 0.07% (2)
bookmarks - 0.07% (2)
tenofovir - 0.07% (2)
publications - 0.07% (2)
number: - 0.07% (2)
content - 0.07% (2)
home - 0.07% (2)
make - 0.07% (2)
happen - 0.07% (2)
lives - 0.07% (2)
free - 0.07% (2)
whether - 0.07% (2)
set - 0.07% (2)
making - 0.07% (2)
sharing - 0.07% (2)
share - 0.07% (2)
recent - 0.07% (2)
leaflets - 0.07% (2)
ritonavir - 0.07% (2)
promise - 0.07% (2)
programmes - 0.07% (2)
cairns - 0.07% (2)
(prep) - 0.07% (2)
inconclusive - 0.07% (2)
study - 0.07% (2)
african - 0.07% (2)
roger - 0.07% (2)
pebody - 0.07% (2)
studies - 0.07% (2)
commissionerview - 0.07% (2)
been - 0.07% (2)
circumcised - 0.07% (2)
accelerated - 0.07% (2)
close - 0.07% (2)
depression - 0.07% (2)
editor's - 0.07% (2)
abacavir - 0.07% (2)
picks - 0.07% (2)
ukraine - 0.07% (2)
england - 0.07% (2)
cancer? - 0.07% (2)
patients - 0.07% (2)
tourism - 0.07% (2)
international - 0.07% (2)
face - 0.07% (2)
daas - 0.07% (2)
wales - 0.07% (2)
cured - 0.07% (2)
keep - 0.07% (2)
tests - 0.07% (2)
load - 0.07% (2)
webcast - 0.07% (2)
legal - 0.07% (2)
york - 0.07% (2)
finance - 0.07% (2)
relationships - 0.07% (2)
feelings - 0.07% (2)
contraception - 0.07% (2)
systems - 0.07% (2)
delivery - 0.07% (2)
condoms - 0.07% (2)
task - 0.07% (2)
shifting - 0.07% (2)
palliative - 0.07% (2)
clinical - 0.07% (2)
activism - 0.07% (2)
pharmaceutical - 0.07% (2)
industry - 0.07% (2)
funding - 0.07% (2)
lubricant - 0.07% (2)
global - 0.07% (2)
initiatives - 0.07% (2)
risks - 0.07% (2)
medicines - 0.07% (2)
theoretical - 0.07% (2)
blood-borne - 0.07% (2)
achieving - 0.07% (2)
90-90-90 - 0.07% (2)
procedures - 0.07% (2)
occurs - 0.07% (2)
ageing - 0.07% (2)
infectiousness - 0.07% (2)
bogus - 0.07% (2)
safer - 0.07% (2)
drug-resistant - 0.07% (2)
cardiovascular - 0.07% (2)
end-of-life - 0.07% (2)
telling - 0.07% (2)
finding - 0.07% (2)
criminal - 0.07% (2)
structural - 0.07% (2)
policing - 0.07% (2)
immigration - 0.07% (2)
money, - 0.07% (2)
benefits - 0.07% (2)
housing - 0.07% (2)
employment - 0.07% (2)
religion - 0.07% (2)
faith - 0.07% (2)
travel - 0.07% (2)
experiences - 0.07% (2)
tuberculosis - 0.07% (2)
spermwashing - 0.07% (2)
discrimination - 0.07% (2)
vaccines - 0.07% (2)
combatting - 0.07% (2)
microbicides - 0.07% (2)
interventions - 0.07% (2)
pep - 0.07% (2)
mother-to-child - 0.07% (2)
infant - 0.07% (2)
feeding - 0.07% (2)
conception - 0.07% (2)
disclosure - 0.07% (2)
diagnosing - 0.07% (2)
developmental - 0.07% (2)
only - 0.07% (2)
diabetes - 0.07% (2)
says - 0.07% (2)
might - 0.07% (2)
each - 0.07% (2)
comprehensive - 0.07% (2)
tools - 0.07% (2)
decisions - 0.07% (2)
chart - 0.07% (2)
restrictions. - 0.07% (2)
italian - 0.07% (2)
diagnosed - 0.07% (2)
resourcesan - 0.07% (2)
countries - 0.07% (2)
talks - 0.07% (2)
diagnoses - 0.07% (2)
bbc2's - 0.07% (2)
2017nam - 0.07% (2)
food - 0.07% (2)
social - 0.07% (2)
questions - 0.07% (2)
some - 0.07% (2)
answers - 0.07% (2)
aids. - 0.07% (2)
news: - 0.07% (2)
update - 0.07% (2)
features - 0.07% (2)
month.when - 0.07% (2)
science, - 0.07% (2)
political - 0.07% (2)
will - 0.07% (2)
epidemic, - 0.07% (2)
booklets - 0.07% (2)
dosing, - 0.07% (2)
malaria - 0.07% (2)
complementary - 0.07% (2)
neurological - 0.07% (2)
cognitive - 0.07% (2)
bone - 0.07% (2)
lipodystrophy - 0.07% (2)
malnutrition - 0.07% (2)
causes - 0.07% (2)
healthy - 0.07% (2)
bad - 0.07% (2)
prognosis - 0.07% (2)
exercise - 0.07% (2)
recreational - 0.07% (2)
alcohol - 0.07% (2)
smoking - 0.07% (2)
therapies - 0.07% (2)
formulation, - 0.07% (2)
immunisations - 0.07% (2)
sleep - 0.07% (2)
treatment-experienced - 0.07% (2)
interruptions - 0.07% (2)
pharmacokinetics - 0.07% (2)
interactions - 0.07% (2)
adherence - 0.07% (2)
one-page - 0.07% (2)
reference - 0.07% (2)
starting - 0.07% (2)
anti-hiv - 0.07% (2)
licensed - 0.07% (2)
european - 0.07% (2)
union, - 0.07% (2)
soon: - 0.07% (2)
hepatitis c - 0.73% (21)
february 2017 - 0.73% (21)
croi 2017 - 0.55% (16)
hiv treatment - 0.52% (15)
hiv and - 0.42% (12)
c infections - 0.38% (11)
of hiv - 0.31% (9)
in the - 0.31% (9)
22 february - 0.31% (9)
with hiv - 0.31% (9)
opportunistic infections - 0.31% (9)
conference on - 0.28% (8)
and hiv - 0.28% (8)
the conference - 0.28% (8)
consensus statement - 0.28% (8)
hiv test - 0.28% (8)
on retroviruses - 0.24% (7)
and opportunistic - 0.24% (7)
retroviruses and - 0.24% (7)
infections (croi - 0.24% (7)
c treatment - 0.24% (7)
people with - 0.21% (6)
and the - 0.21% (6)
what is - 0.21% (6)
more news - 0.21% (6)
and children - 0.21% (6)
(croi 2017) - 0.21% (6)
for more - 0.17% (5)
hiv testing - 0.17% (5)
prep in - 0.17% (5)
children | - 0.17% (5)
for hiv - 0.17% (5)
news from - 0.17% (5)
at the - 0.17% (5)
living with - 0.17% (5)
emotional health - 0.17% (5)
hepatitis a - 0.17% (5)
conference webpages - 0.17% (5)
to your - 0.17% (5)
have hiv - 0.17% (5)
our conference - 0.17% (5)
hours ago - 0.17% (5)
and aids - 0.17% (5)
webpages for - 0.17% (5)
mental and - 0.17% (5)
people a - 0.17% (5)
and emotional - 0.17% (5)
access to - 0.17% (5)
health monitoring - 0.17% (5)
of the - 0.17% (5)
of oral - 0.14% (4)
bacterial vaginosis - 0.14% (4)
and treatment - 0.14% (4)
and experimental - 0.14% (4)
with a - 0.14% (4)
how hiv - 0.14% (4)
treatment in - 0.14% (4)
linkage to - 0.14% (4)
and personal - 0.14% (4)
families and - 0.14% (4)
health services - 0.14% (4)
in children - 0.14% (4)
new and - 0.14% (4)
treatment | - 0.14% (4)
not affect - 0.14% (4)
this section - 0.14% (4)
in this - 0.14% (4)
23 february - 0.14% (4)
efficacy of - 0.14% (4)
out the - 0.14% (4)
on the - 0.14% (4)
direct-acting antiviral - 0.14% (4)
community consensus - 0.14% (4)
you have - 0.14% (4)
in seattle, - 0.14% (4)
search for - 0.14% (4)
from a - 0.14% (4)
& aids - 0.14% (4)
we can - 0.14% (4)
retention and - 0.1% (3)
among hiv-positive - 0.1% (3)
gay men - 0.1% (3)
kidney problems - 0.1% (3)
to care - 0.1% (3)
new hepatitis - 0.1% (3)
decline in - 0.1% (3)
croi 2017: - 0.1% (3)
problems | - 0.1% (3)
care | - 0.1% (3)
took place - 0.1% (3)
transmitted infections - 0.1% (3)
usa earlier - 0.1% (3)
together, we - 0.1% (3)
and linkage - 0.1% (3)
place in - 0.1% (3)
earlier this - 0.1% (3)
from croi - 0.1% (3)
who are - 0.1% (3)
an hiv - 0.1% (3)
guide to - 0.1% (3)
does not - 0.1% (3)
affect efficacy - 0.1% (3)
to support - 0.1% (3)
that prep - 0.1% (3)
prep users - 0.1% (3)
with information - 0.1% (3)
pre-exposure prophylaxis - 0.1% (3)
seattle, usa - 0.1% (3)
monoclonal antibodies - 0.1% (3)
hiv treatments - 0.1% (3)
treatment options - 0.1% (3)
sexually transmitted - 0.1% (3)
very high - 0.1% (3)
news croi - 0.1% (3)
information is - 0.1% (3)
2017) took - 0.1% (3)
evidence that - 0.1% (3)
undetectable equals - 0.1% (3)
epidemiology and - 0.1% (3)
the uk - 0.1% (3)
have an - 0.1% (3)
reproductive health - 0.1% (3)
and behaviour - 0.1% (3)
harm reduction - 0.1% (3)
sexual transmission - 0.1% (3)
a cure - 0.1% (3)
transmission and - 0.1% (3)
and prevention - 0.1% (3)
for women - 0.1% (3)
| treatment - 0.1% (3)
nam endorses - 0.1% (3)
january 2017 - 0.1% (3)
this section. - 0.1% (3)
cd4 count - 0.1% (3)
is aids? - 0.1% (3)
is hiv? - 0.1% (3)
hiv-positive gay - 0.1% (3)
infections among - 0.1% (3)
news feeds - 0.1% (3)
in women - 0.1% (3)
oral prep - 0.1% (3)
vaginosis does - 0.1% (3)
statement on - 0.1% (3)
hiv drugs - 0.1% (3)
co-infection who - 0.1% (3)
the community - 0.1% (3)
| drug - 0.1% (3)
experimental hiv - 0.1% (3)
can end - 0.1% (3)
transmission | - 0.1% (3)
consent and - 0.1% (3)
services and - 0.1% (3)
medical ethics - 0.1% (3)
half after - 0.07% (2)
drug policy - 0.07% (2)
26 february - 0.07% (2)
or another - 0.07% (2)
your doctor - 0.07% (2)
talk to - 0.07% (2)
healthcare professional. - 0.07% (2)
replace, consultation - 0.07% (2)
rather than - 0.07% (2)
roll-out in - 0.07% (2)
to support, - 0.07% (2)
ago people - 0.07% (2)
member of - 0.07% (2)
and policing - 0.07% (2)
is intended - 0.07% (2)
about the - 0.07% (2)
nam’s information - 0.07% (2)
rates in - 0.07% (2)
on hepatitis - 0.07% (2)
health initiatives - 0.07% (2)
very high, - 0.07% (2)
drop by - 0.07% (2)
team for - 0.07% (2)
your healthcare - 0.07% (2)
2017 hepatitis - 0.07% (2)
the epidemic, - 0.07% (2)
says new - 0.07% (2)
bone problems - 0.07% (2)
to medicines - 0.07% (2)
2017 more - 0.07% (2)
use for - 0.07% (2)
york commissionerview - 0.07% (2)
a webcast - 0.07% (2)
and its - 0.07% (2)
of this - 0.07% (2)
but evidence - 0.07% (2)
presentation on - 0.07% (2)
websiteread our - 0.07% (2)
news bulletinsvisit - 0.07% (2)
nam publications - 0.07% (2)
of care - 0.07% (2)
24 february - 0.07% (2)
medical tourism - 0.07% (2)
our news - 0.07% (2)
c virus - 0.07% (2)
advice tailored - 0.07% (2)
2017 30 - 0.07% (2)
in care - 0.07% (2)
soon: news - 0.07% (2)
cairns | - 0.07% (2)
tb transmission - 0.07% (2)
tb symptoms - 0.07% (2)
tb services - 0.07% (2)
pebody | - 0.07% (2)
legal issues - 0.07% (2)
hiv from - 0.07% (2)
social and - 0.07% (2)
is inconclusive - 0.07% (2)
treatment hiv - 0.07% (2)
2017 a - 0.07% (2)
telling people - 0.07% (2)
presented at - 0.07% (2)
relationships and - 0.07% (2)
no evidence - 0.07% (2)
roger pebody - 0.07% (2)
pharmaceutical industry - 0.07% (2)
who have - 0.07% (2)
men who - 0.07% (2)
hiv causes - 0.07% (2)
well with - 0.07% (2)
have been - 0.07% (2)
tb treatment - 0.07% (2)
gus cairns - 0.07% (2)
increases them - 0.07% (2)
editor's picks - 0.07% (2)
as prevention - 0.07% (2)
newsnight 22 - 0.07% (2)
hcv co-infection - 0.07% (2)
on bbc2's - 0.07% (2)
hiv diagnoses - 0.07% (2)
cured of - 0.07% (2)
with daas - 0.07% (2)
at increased - 0.07% (2)
risk for - 0.07% (2)
liver cancer? - 0.07% (2)
about prep - 0.07% (2)
women women - 0.07% (2)
liz highleyman - 0.07% (2)
ageing and - 0.07% (2)
director talks - 0.07% (2)
viral load - 0.07% (2)
uk health - 0.07% (2)
hepatitis b - 0.07% (2)
treatment for - 0.07% (2)
hiv prevention - 0.07% (2)
mental health - 0.07% (2)
21 february - 0.07% (2)
from other - 0.07% (2)
--> nam - 0.07% (2)
will come - 0.07% (2)
and legal - 0.07% (2)
and faith - 0.07% (2)
and housing - 0.07% (2)
money, benefits - 0.07% (2)
policy and - 0.07% (2)
criminal law - 0.07% (2)
people you - 0.07% (2)
prevention policy - 0.07% (2)
experiences of - 0.07% (2)
| epidemiology - 0.07% (2)
change interventions - 0.07% (2)
condoms and - 0.07% (2)
theoretical transmission - 0.07% (2)
low and - 0.07% (2)
other blood-borne - 0.07% (2)
procedures and - 0.07% (2)
issues | - 0.07% (2)
stigma | - 0.07% (2)
prevention | - 0.07% (2)
tb vaccine - 0.07% (2)
and systems - 0.07% (2)
and feelings - 0.07% (2)
safer sex - 0.07% (2)
and sex - 0.07% (2)
drug-resistant tb - 0.07% (2)
tb diagnosis - 0.07% (2)
tb prevention - 0.07% (2)
for families - 0.07% (2)
discrimination and - 0.07% (2)
developmental issues - 0.07% (2)
diagnosing children - 0.07% (2)
disclosure and - 0.07% (2)
of mother-to-child - 0.07% (2)
| hepatitis - 0.07% (2)
combatting stigma - 0.07% (2)
the law - 0.07% (2)
how transmission - 0.07% (2)
treatment as - 0.07% (2)
task shifting - 0.07% (2)
for hiv-positive - 0.07% (2)
by half - 0.07% (2)
men drop - 0.07% (2)
resistance reported - 0.07% (2)
without drug - 0.07% (2)
prep failure - 0.07% (2)
case of - 0.07% (2)
limited treatment - 0.07% (2)
show promise - 0.07% (2)
antiviral roll-out - 0.07% (2)
for liver - 0.07% (2)
increased risk - 0.07% (2)
daas at - 0.07% (2)
c with - 0.07% (2)
of hepatitis - 0.07% (2)
are cured - 0.07% (2)
and hcv - 0.07% (2)
after direct-acting - 0.07% (2)
hiv infections - 0.07% (2)
infectiousness and - 0.07% (2)
treatment guidelines - 0.07% (2)
and bogus - 0.07% (2)
bad science - 0.07% (2)
the search - 0.07% (2)
outcomes and - 0.07% (2)
treatment interruptions - 0.07% (2)
and pharmacokinetics - 0.07% (2)
drug interactions - 0.07% (2)
monitoring hiv - 0.07% (2)
one of - 0.07% (2)
and health - 0.07% (2)
found out - 0.07% (2)
might have - 0.07% (2)
is not - 0.07% (2)
you might - 0.07% (2)
how is - 0.07% (2)
hiv research - 0.07% (2)
delivery of - 0.07% (2)
clinical trials - 0.07% (2)
and political - 0.07% (2)
bbc2's newsnight - 0.07% (2)
about hiv - 0.07% (2)
contact us - 0.07% (2)
30 january - 0.07% (2)
09 february - 0.07% (2)
untransmittable (u=u) - 0.07% (2)
aidsmap hiv - 0.07% (2)
diagnoses on - 0.07% (2)
conference news: - 0.07% (2)
in hiv - 0.07% (2)
the decline - 0.07% (2)
prep and - 0.07% (2)
talks about - 0.07% (2)
services in - 0.07% (2)
hiv services - 0.07% (2)
food restrictions. - 0.07% (2)
and aids. - 0.07% (2)
month.when science, - 0.07% (2)
dosing, key - 0.07% (2)
conference websiteread - 0.07% (2)
science, community - 0.07% (2)
this month.when - 0.07% (2)
2017 the - 0.07% (2)
news: croi - 0.07% (2)
bulletinsvisit our - 0.07% (2)
2017 news - 0.07% (2)
our croi - 0.07% (2)
this presentation - 0.07% (2)
community and - 0.07% (2)
webcast of - 0.07% (2)
commissionerview a - 0.07% (2)
new york - 0.07% (2)
epidemic, says - 0.07% (2)
end the - 0.07% (2)
come together, - 0.07% (2)
political will - 0.07% (2)
side-effects and - 0.07% (2)
on formulation, - 0.07% (2)
finance and - 0.07% (2)
hiv works - 0.07% (2)
of topics - 0.07% (2)
full list - 0.07% (2)
low cd4 - 0.07% (2)
living well - 0.07% (2)
drug use - 0.07% (2)
healthy living - 0.07% (2)
causes disease - 0.07% (2)
cognitive problems - 0.07% (2)
to the - 0.07% (2)
neurological and - 0.07% (2)
health | - 0.07% (2)
health problems - 0.07% (2)
90-90-90 target - 0.07% (2)
achieving the - 0.07% (2)
medicines and - 0.07% (2)
global health - 0.07% (2)
reference guide - 0.07% (2)
anti-hiv drugs - 0.07% (2)
european union, - 0.07% (2)
list of - 0.07% (2)
for use - 0.07% (2)
drugs licensed - 0.07% (2)
the anti-hiv - 0.07% (2)
one-page reference - 0.07% (2)
antiretroviral drugs - 0.07% (2)
series of - 0.07% (2)
the basics - 0.07% (2)
for people - 0.07% (2)
licensed for - 0.07% (2)
and food - 0.07% (2)
key side-effects - 0.07% (2)
formulation, dosing, - 0.07% (2)
information on - 0.07% (2)
union, with - 0.07% (2)
the european - 0.07% (2)
use in - 0.07% (2)
the most - 0.07% (2)
22 february 2017 - 0.31% (9)
and opportunistic infections - 0.24% (7)
retroviruses and opportunistic - 0.24% (7)
hepatitis c treatment - 0.24% (7)
conference on retroviruses - 0.24% (7)
infections (croi 2017) - 0.21% (6)
| 22 february - 0.21% (6)
the conference on - 0.21% (6)
webpages for more - 0.17% (5)
conference webpages for - 0.17% (5)
and emotional health - 0.17% (5)
for more news - 0.17% (5)
our conference webpages - 0.17% (5)
efficacy of oral - 0.14% (4)
community consensus statement - 0.14% (4)
people and personal - 0.14% (4)
families and children - 0.14% (4)
23 february 2017 - 0.14% (4)
hiv & aids - 0.14% (4)
with hiv and - 0.1% (3)
what is hiv? - 0.1% (3)
retention and linkage - 0.1% (3)
news from croi - 0.1% (3)
consent and medical - 0.1% (3)
and linkage to - 0.1% (3)
of hiv and - 0.1% (3)
linkage to care - 0.1% (3)
hiv-positive gay men - 0.1% (3)
sexually transmitted infections - 0.1% (3)
took place in - 0.1% (3)
experimental hiv treatments - 0.1% (3)
we can end - 0.1% (3)
of oral prep - 0.1% (3)
not affect efficacy - 0.1% (3)
more news croi - 0.1% (3)
bacterial vaginosis does - 0.1% (3)
news croi 2017: - 0.1% (3)
does not affect - 0.1% (3)
(croi 2017) took - 0.1% (3)
place in seattle, - 0.1% (3)
usa earlier this - 0.1% (3)
seattle, usa earlier - 0.1% (3)
(u=u) consensus statement - 0.1% (3)
history of hiv - 0.1% (3)
vaginosis does not - 0.1% (3)
hiv treatment and - 0.1% (3)
in this section. - 0.1% (3)
what is aids? - 0.1% (3)
the community consensus - 0.1% (3)
among hiv-positive gay - 0.1% (3)
and experimental hiv - 0.1% (3)
oral prep in - 0.1% (3)
affect efficacy of - 0.1% (3)
epidemiology and behaviour - 0.1% (3)
and medical ethics - 0.1% (3)
co-infection who are - 0.1% (3)
hepatitis c with - 0.07% (2)
pre-exposure prophylaxis (prep) - 0.07% (2)
sti rates in - 0.07% (2)
on access to - 0.07% (2)
team for advice - 0.07% (2)
of your healthcare - 0.07% (2)
or another member - 0.07% (2)
liz highleyman | - 0.07% (2)
its use for - 0.07% (2)
with limited treatment - 0.07% (2)
statement is a - 0.07% (2)
for hiv-positive people - 0.07% (2)
antibodies show promise - 0.07% (2)
consensus statement is - 0.07% (2)
are cured of - 0.07% (2)
gus cairns | - 0.07% (2)
to your doctor - 0.07% (2)
nam’s information is - 0.07% (2)
intended to support, - 0.07% (2)
rather than replace, - 0.07% (2)
hcv co-infection who - 0.07% (2)
consultation with a - 0.07% (2)
healthcare professional. talk - 0.07% (2)
hepatitis c virus - 0.07% (2)
hours ago people - 0.07% (2)
risk for liver - 0.07% (2)
daas at increased - 0.07% (2)
and its use - 0.07% (2)
high, but evidence - 0.07% (2)
prep users very - 0.07% (2)
about prep and - 0.07% (2)
medical procedures and - 0.07% (2)
other blood-borne exposure - 0.07% (2)
talk to your - 0.07% (2)
a healthcare professional. - 0.07% (2)
replace, consultation with - 0.07% (2)
nam's director talks - 0.07% (2)
the decline in - 0.07% (2)
hiv treatment in - 0.07% (2)
hiv diagnoses on - 0.07% (2)
bbc2's newsnight 22 - 0.07% (2)
endorses undetectable equals - 0.07% (2)
untransmittable (u=u) consensus - 0.07% (2)
statement 09 february - 0.07% (2)
support, rather than - 0.07% (2)
2017 30 january - 0.07% (2)
doctor or another - 0.07% (2)
and hiv hepatitis - 0.07% (2)
is intended to - 0.07% (2)
healthcare team for - 0.07% (2)
that prep increases - 0.07% (2)
them is inconclusive - 0.07% (2)
to hiv treatment - 0.07% (2)
statement on access - 0.07% (2)
men who have - 0.07% (2)
21 february 2017 - 0.07% (2)
advice tailored to - 0.07% (2)
on hepatitis c - 0.07% (2)
health services and - 0.07% (2)
26 february 2017 - 0.07% (2)
february 2017 hepatitis - 0.07% (2)
24 february 2017 - 0.07% (2)
member of your - 0.07% (2)
to medicines and - 0.07% (2)
interactions and pharmacokinetics - 0.07% (2)
drug policy and - 0.07% (2)
and theoretical transmission - 0.07% (2)
aidsmap hiv & - 0.07% (2)
resistance reported from - 0.07% (2)
support for families - 0.07% (2)
people you have - 0.07% (2)
and criminal law - 0.07% (2)
benefits and housing - 0.07% (2)
religion and faith - 0.07% (2)
experiences of stigma - 0.07% (2)
prevention of mother-to-child - 0.07% (2)
treatment in children - 0.07% (2)
disclosure and children - 0.07% (2)
and children | - 0.07% (2)
low and theoretical - 0.07% (2)
uk health services - 0.07% (2)
access to medicines - 0.07% (2)
achieving the 90-90-90 - 0.07% (2)
ageing and hiv - 0.07% (2)
emotional health | - 0.07% (2)
neurological and cognitive - 0.07% (2)
with a low - 0.07% (2)
full list of - 0.07% (2)
condoms and lubricant - 0.07% (2)
procedures and other - 0.07% (2)
to the anti-hiv - 0.07% (2)
hepatitis c infections - 0.07% (2)
cured of hepatitis - 0.07% (2)
c with daas - 0.07% (2)
at increased risk - 0.07% (2)
for liver cancer? - 0.07% (2)
promise for hiv-positive - 0.07% (2)
people with limited - 0.07% (2)
of prep failure - 0.07% (2)
without drug resistance - 0.07% (2)
men drop by - 0.07% (2)
and treatment as - 0.07% (2)
half after direct-acting - 0.07% (2)
antiviral roll-out in - 0.07% (2)
you might have - 0.07% (2)
just found out - 0.07% (2)
testing and health - 0.07% (2)
drug interactions and - 0.07% (2)
the search for - 0.07% (2)
bad science and - 0.07% (2)
one-page reference guide - 0.07% (2)
drugs licensed for - 0.07% (2)
failure without drug - 0.07% (2)
this presentation on - 0.07% (2)
hiv and aids. - 0.07% (2)
news: croi 2017 - 0.07% (2)
this month.when science, - 0.07% (2)
community and political - 0.07% (2)
will come together, - 0.07% (2)
the epidemic, says - 0.07% (2)
new york commissionerview - 0.07% (2)
a webcast of - 0.07% (2)
the conference websiteread - 0.07% (2)
soon: news from - 0.07% (2)
our croi 2017 - 0.07% (2)
news bulletinsvisit our - 0.07% (2)
hiv and hcv - 0.07% (2)
rates in prep - 0.07% (2)
users very high, - 0.07% (2)
but evidence that - 0.07% (2)
prep increases them - 0.07% (2)
case of prep - 0.07% (2)
croi 2017 30 - 0.07% (2)
one of the - 0.07% (2)
use in the - 0.07% (2)
the european union, - 0.07% (2)
european union, with - 0.07% (2)
information on formulation, - 0.07% (2)
dosing, key side-effects - 0.07% (2)
antiretroviral drugs chart - 0.07% (2)
a one-page reference - 0.07% (2)
guide to the - 0.07% (2)
anti-hiv drugs licensed - 0.07% (2)
for use in - 0.07% (2)
with information on - 0.07% (2)
consensus statement 09 - 0.07% (2)
formulation, dosing, key - 0.07% (2)
side-effects and food - 0.07% (2)
services in the - 0.07% (2)
talks about prep - 0.07% (2)
and the decline - 0.07% (2)
in hiv diagnoses - 0.07% (2)
on bbc2's newsnight - 0.07% (2)
equals untransmittable (u=u) - 0.07% (2)
tailored to your - 0.07% (2)

Here you can find chart of all your popular one, two and three word phrases. Google and others search engines means your page is about words you use frequently.

Copyright © 2015-2016 hupso.pl. All rights reserved. FB | +G | Twitter

Hupso.pl jest serwisem internetowym, w którym jednym kliknieciem możesz szybko i łatwo sprawdź stronę www pod kątem SEO. Oferujemy darmowe pozycjonowanie stron internetowych oraz wycena domen i stron internetowych. Prowadzimy ranking polskich stron internetowych oraz ranking stron alexa.